When science stays the course, time becomes part of the treatment.
Emerging data from ESMO 2025 highlight encouraging activity of the oncolytic virus RP1 plus nivolumab across several advanced non‑melanoma skin cancers, especially in PD‑1 naive and refractory settings.
Six weeks into my journey at AdventHealth, I’ve been both energized and humbled by what I’ve encountered. From the size and scale of the hospital system to the innovation in cancer care and research, here are 12 things that have stood out to me in a big way: 1. AdventHealth Orlando Is Massive — and …
A year defined by intentional choices—strengthening clinical excellence, embracing innovation, and building the personal and financial stability needed to care well for patients, teams, and family.
Living with intention means honoring time, embracing presence, and returning to purpose with a full heart.
A firewall against relapse — adjuvant immunotherapy steps into the spotlight for resected Merkel cell carcinoma.
Protecting vision, preserving the person — the promise of ocular-sparing oncology.
Two moments in small cell lung cancer — a missed opportunity and a new therapeutic option — remind us how timing and innovation continue to shape outcomes.
A year of locum work, a patient’s change of heart, and my own renewal remind me that truth, patience, and hope still matter — in medicine and in life.
Caregiving during immunotherapy means balancing vigilance with compassion — for your loved one, and for yourself.